<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Achyranthes bidentata <z:chebi fb="1" ids="15841">polypeptides</z:chebi> (ABPP), the important constituents separated from the aqueous extract of Achyranthes bidentata, have been shown to attenuate <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>)-induced cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in cultured hippocampal neurons through differential modulation of NR2A- and NR2B-containing <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
<SENT sid="1" pm="."><plain>The present study sought to investigate the possible mechanism underlying the neuroprotective effect of ABPP on <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Western blot analysis and colorimetric enzymatic assay demonstrated that ABPP pretreatment inhibited <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced increase of Bax protein expression or caspase-3 activity in cultured hippocampal neurons </plain></SENT>
<SENT sid="3" pm="."><plain>Fluorescence measurements after staining with 2,7-dichlorofluorescin diacetate and <z:chebi fb="0" ids="8828">rhodamine 123</z:chebi> showed that ABPP treatment also reversed <z:chebi fb="0" ids="31882">NMDA</z:chebi>-induced intracellular radical oxygen species (ROS) elevation and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane potential <z:hpo ids='HP_0000716'>depression</z:hpo> in cultured hippocampal neurons </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, the in vivo effects of ABPP on cerebral neuronal damage during focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion were also investigated </plain></SENT>
<SENT sid="5" pm="."><plain>In rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model, ABPP attenuated the increase in the neurological deficit and <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> induced by focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion, showing in vivo neuroprotective effects </plain></SENT>
<SENT sid="6" pm="."><plain>The results collectively suggest that ABPP might exert neuroprotective actions through inhibiting Bax protein expression, caspase-3 activity, ROS production, and <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction that are <z:hpo ids='HP_0000001'>all</z:hpo> caused by overstimulation of <z:chebi fb="0" ids="31882">NMDA</z:chebi> receptors </plain></SENT>
</text></document>